#OTC Markets Group - News

[probablyasocialecologist]

It’s a cartel in the classic economic and business sense—OPEC, not Sinaloa—a small group of connected actors working together to dominate a market that they only recently helped create. For crypto, where money is fake, value is purely hype-based, and new tokens can be spun out of nothing, it makes perfect sense. It’s a small industry, notionally worth $3 trillion at its peak in November 2021 but now hovering around $1 trillion. Many leading crypto luminaries know each other, interact on social media, trade with each other, and hobnob at small private gatherings like the Satoshi Roundtable, an annual invite-only meeting of select crypto insiders. Last spring, I confirmed via some attendees that Jean-Louis van der Velde, Tether’s elusive Hong Kong-based CEO, was at the invite-only FTX conference in the Bahamas, alongside luminaries like Bill Clinton and Tony Blair. In a public Twitter exchange, Bankman-Fried—whose Alameda hedge fund allegedly bought at least $36 billion worth of Tether in just a few years—said he didn’t know if van der Velde was there. I didn’t believe him. Many crypto power players have histories with poker, online gambling, offshore finance, and/or other gray-market economies. A lot of them do business via so-called OTC, or over the counter, trades: person-to-person exchanges that might not leave a trace on the blockchain, crypto’s supposedly transparent public ledger. Over time, the industry, including its black-market participants, has developed its own protocols, social codes, and, as interests aligned, what amounted to an omerta. What was good for one member was often good for the rest.

[bangla24]

"Navigating Financial Markets: A Beginner's Guide to Investment Success"

Financial markets refer broadly to any marketplace where securities trading occurs, including the stock market, bond market, forex market, and derivatives market. Financial markets are vital to the smooth operation of capitalist economies.

What Are Financial Markets?

Financial Markets include any place or system that provides buyers and sellers the means to trade financial instruments, including bonds, equities, the various international currencies, and derivatives. Financial markets facilitate the interaction between those who need capital with those who have capital to invest.

Types of Financial Markets

There are several different types of markets. Each one focuses on the types and classes of instruments available on it.The following are different types of financial markets:

Stock Market.

Bond market.

Foreign Exchange Markets.

Commodity markets.

Derivative Market.

Futures Market.

Over-the-counter (OTC) Market.

Stock Market

Perhaps the most ubiquitous of financial markets are stock markets. These are venues where companies list their shares, which are bought and sold by traders and investors. Stock markets, or equities markets, are used by companies to raise capital and by investors to search for returns. Most stock trading is done via regulated exchanges, which plays an important economic role because it is another way for money to flow through the economy.

Bond market

Bonds are issued by corporations as well as by municipalities, states, and sovereign governments to finance projects and operations.For example, the bond market sells securities such as notes and bills issued by the United States Treasury. The bond market is also called the debt, credit, or fixed-income market.

Foreign Exchange Markets.

The Foreign Exchange Market (commonly known as the Forex Market or FX Market) is a global decentralized marketplace where currencies are traded. It is the largest financial market in the world, with a daily trading volume exceeding $7 trillion as of recent estimates. The Forex market operates 24 hours a day, five days a week, enabling participants from different time zones to engage in trading activities continuously.

Commodity Markets

Commodities markets are venues where producers and consumers meet to exchange physical commodities such as agricultural products (e.g., corn, livestock, soybeans), energy products (oil, gas, carbon credits), precious metals (gold, silver,platinum).

These are known as spot commodity markets, where physical goods are exchanged for money.However, the bulk of trading in these commodities takes place on derivatives markets that utilize spot commodities as the underlying assets.

Derivative Market

Derivatives are financial instruments whose value is derived from an underlying asset or a group of assets. These assets range from stocks, bonds, commodities, currencies, interest rates, or market indices. The derivatives market is a financial marketplace where derivative contracts are bought and sold.

A derivative is a contract between two or more parties whose value is based on an agreed-upon underlying financial asset (like a security) or set of assets (like an index).Rather than trading stocks directly, a derivatives market trades in futures and options contracts and other advanced financial products that derive their value from underlying instruments like bonds, commodities, currencies, interest rates, market indexes, and stocks.

Futures Market

Futures markets are where futures contracts are listed and traded. Unlike forwards, which trade OTC, futures markets utilize standardized contract specifications, are well-regulated, and use clearinghouses to settle and confirm trades.

Options markets, such as the Chicago Board Options Exchange (CBOE), similarly list and regulate options contracts. Both futures and options exchanges may list contracts on various asset classes, such as equities, fixed-income securities, commodities, and so on.

OTC Market

An over- the- counter (OTC) market is a decentralized market—meaning it does not have physical locations, and trading is conducted electronically—in which market participants trade securities directly (meaning without a broker).While OTC markets may handle trading in certain stocks (e.g., smaller or riskier companies that do not meet the listing criteria of exchanges), most stock trading is done via exchanges.

Certain derivatives markets, however, are exclusively OTC, making up an essential segment of the financial markets. Broadly speaking, OTC markets and the transactions that occur in them are far less regulated, less liquid, and more opaque.

Examples of Financial Markets

The above sections make clear that the "financial markets" are broad in scope and scale. To give two more concrete examples, we will consider the role of stock markets in bringing a company to IPO and the role of the OTC derivatives market in the 2008-09 financial crisis.

How Do Financial Markets Work?

Despite covering many different asset classes and having various structures and regulations, all financial markets work essentially by bringing together buyers and sellers in some asset or contract and allowing them to trade with one another. This is often done through an auction or price - discovery mechanism.

What Are the Main Functions of Financial Markets?

Financial markets exist for several reasons, but the most fundamental function is to allow for the efficient allocation of capital and assets in a financial economy. By allowing a free market for the flow of capital, financial obligations, and money, the financial markets make the global economy run more smoothly while allowing investors to participate in capital gains over time.

The Bottom Line

Financial markets provide liquidity, capital, and participation that are essential for economic growth and stability. Without financial markets, capital could not be allocated efficiently, and economic activity such as commerce and trade, investments, and growth opportunities would be greatly diminished.

Many players make markets an essential part of the economy—firms use stock and bond markets to raise capital from investors. Speculators look to various asset classes to make directional bets on future prices.

At the same time, hedgers use derivatives markets to mitigate various risks, and arbitrageurs seek to take advantage of mispricings or anomalies observed across various markets. Brokers often act as mediators that bring buyers and sellers together, earning a commission or fee for their services.

Compete Risk Free with $100,000 in Virtual Cash

Put your trading skills to the test with our free stock simulator. Compete with thousands of Investopedia traders and trade your way to the top! Submit trades in a virtual environment before you start risking your own money. Practice trading strategies so that when you're ready to enter the real market, you've had the practice you need. 

Steps to Begin Investing in Financial Markets

Educate Yourself:

Learn the basics of financial instruments and how markets operate. Books, online courses, and tutorials are excellent resources.

Set Clear Goals:

Define your investment objectives, whether it’s saving for retirement, purchasing a home, or building wealth.

Determine Your Risk Tolerance:

Assess how much risk you’re comfortable taking. Younger investors might take more risks, while those nearing retirement may prefer safer investments.

Choose the Right Market:

Decide whether to focus on stocks, bonds, forex, or a mix, depending on your goals.

Open a Trading Account:

Select a reputable broker or trading platform that aligns with your investment preferences and provides user-friendly tools.

Start Small:

Begin with modest investments to gain experience and confidence.

Monitor and Adjust:

Keep track of your portfolio’s performance and make adjustments as needed to stay on track with your goals.

Common Mistakes to Avoid

Lack of Research:

Investing without understanding the market or the asset can lead to losses.

Overtrading:

Frequent buying and selling can erode returns due to fees and poor timing.

Ignoring Risk Management:

Always set stop-loss orders and consider hedging strategies to limit potential losses.

Chasing Trends:

Avoid following market hype without assessing its long-term viability.

Neglecting Diversification:

Overconcentration in a single asset or sector can magnify risks.

Conclusion

Financial markets are the backbone of the global economy, providing a platform for investment, risk management, and wealth creation. Understanding their structure and dynamics is essential for anyone looking to navigate the world of finance effectively. Whether you’re an investor or simply curious about the markets, staying informed is the first step toward making confident and informed decisions.

Navigating financial markets may seem challenging at first, but with education, clear goals, and disciplined strategies, anyone can become a successful investor. Start small, stay informed, and focus on long-term growth to make the most of the opportunities financial markets offer. Remember, investing is a journey, not a sprint, so approach it with patience and confidence.

[sarahharmonbranding]

Product diffusion from the past -- Is it a bad sign that I've barely heard of these?

I really enjoyed this week's case, which covered the early product diffusion process of four offerings: a pre-packaged slice of peanut butter, a silver-lined bandage, Sirius/XM radios, and an "odor printer". I was struck by the absurdity of most of these offerings, despite the very real coverage they earned at the time, and the fact that with the exception of one, I'd never even heard of them. The case asked for our ranked analysis of which products will diffuse most quickly/broadly. Here are my thoughts:

Sirus/XM radio. While known to me as a single entity, Sirius and XM were once competitors in the emerging pay-for-radio space. The business case is clear: commuters and drivers who spend significant time in their car each day were unsatisfied with the unreliable, ad-riddled, and un-customizable radio experience. Sirius/XM had insight into their customer base, size, and could estimate who was willing to pay for more targeted, high quality content. Pair this with a deal to offer the service with car purchases from GM, Ford, and Chrysler, and you've removed significant barriers for customers to adopt the product. No wonder this is the only offering I've heard of.

Westaim Biomedical silver bandages. As someone who grew up in the small town of Exeter, NH I was excited to see a company from Exeter represented in the case. The bad news: I, nor my friends or family, have ever heard of it. However, that does not mean it was all bad for Westaim. While anecdotally it seems the silver bandages did not reach OTC consumer appeal, the company had insight into its addressable market and proven efficacy in medical applications like chronic wounds. My guess is that the patent was acquired or is maybe used in more specialized hospital settings today, which is still a relative win for diffusion.

Pre-packaged slice of peanut butter. This offering feels like nothing more than a spoof food item, and I doubt it had mass diffusion in the consumer market. On the plus side, the company did appear to try and solve a problem faced by its consumers (peanut butter pulled on soft bread when making a PB&J) and thus had a better chance of diffusion than one less researched. While I believe society is always looking for a shortcut, this might be one step too far and too unnecessary. Maybe the better product is the R&D put into non-stick packaging--now THAT could be useful in several applications.

"Odor spray/printer". This idea was both ridiculous and broad. Who were they appealing to? The article mentioned "foodies", or people with a heightened appreciation for the value of good smell, but overall the product strategy felt directionless and unattainable. Seeing as I've never heard of such a thing, I imagine this idea died before there was even a product to test.

Doing these types of thought exercises has been valuable as my Branding group thinks about our project addressing Peloton. Peloton has most likely reached its peak diffusion when it comes to its hardware bike. Peloton now has to re-brand to diffuse a new product offering, its fitness software, and gauge a whole new group of customers for potential adoption. This won't be easy, as YouTube, Instagram, TikTok, and even gyms have begun offering similar content.

[willyskristina]

Antacids Market

Antacids Market Size, Share, Trends: GlaxoSmithKline plc Leads

Shift Towards Natural and Organic Antacid Formulations

Market Overview:

The global antacids market is projected to grow at a CAGR of 4.8% from 2024 to 2031. The market value is expected to increase from USD YY billion in 2024 to USD YY billion by 2031. Asia-Pacific is currently the fastest-growing region, while North America holds the largest market share. Key metrics include the rising prevalence of gastroesophageal reflux disease (GERD), increasing over-the-counter (OTC) availability of antacids, and growing awareness about digestive health. The antacids industry is steadily expanding, driven by causes such as changing food patterns, rising stress levels, and an ageing population. The trend of self-medication for minor digestive disorders is also driving market growth, particularly in the OTC sector. 

DOWNLOAD FREE SAMPLE

Market Trends:

The antacids market is experiencing a considerable shift towards natural and organic formulations. Consumers are increasingly looking for alternatives to traditional chemical-based antacids, citing a desire for healthier products with fewer side effects. This trend is particularly noticeable in the increasing popularity of antacids containing natural calcium carbonate, aloe vera, and herbal extracts. Manufacturers are responding to this trend by developing new product lines that emphasize natural ingredients and environmentally friendly production processes. For example, a leading antacid brand reported a 15% increase in sales of its natural formulation line in 2023 compared to the previous year. This trend is expected to continue, with industry data indicating that 30% of antacid users prefer natural or organic products.

Market Segmentation:

Proton Pump Inhibitors (PPIs) dominate the global antacids market, accounting for the largest share of revenue. PPIs continue to lead the antacids market due to their high efficacy in treating acid-related conditions such as GERD, peptic ulcers, and Zollinger-Ellison syndrome. PPIs work by inhibiting the enzyme responsible for acid production in the stomach, providing long-term relief from acid reflux symptoms. PPIs' dominance is supported by their widespread availability in prescription and over-the-counter formulations. According to the American Gastroenterological Association, PPIs account for more than half of all prescriptions for acid-suppressive medications. In the OTC market, PPI sales have consistently grown, with retail sales increasing by 3.5% in 2023 compared to the previous year.

Recent advancements in the PPI market have focused on addressing concerns about long-term use and improving patient compliance. For instance, in 2023, a major pharmaceutical company launched a new PPI formulation with a faster onset of action and a lower risk of drug interactions. This innovation aims to address some of the concerns associated with traditional PPI formulations while maintaining their efficacy. The PPI segment has also faced increased competition from generic manufacturers, especially as key brand patents have expired. This has led to price reductions and increased accessibility, driving market growth. However, it has also increased the need for branded PPI manufacturers to innovate and differentiate their products.

Market Key Players:

GlaxoSmithKline plc

Pfizer Inc.

Johnson & Johnson

Bayer AG

Sanofi

Reckitt Benckiser Group plc

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[blockinsider]

Metaplanet Bolsters Bitcoin Approach Amidst BTC Downturn Under $96k

Key Points

Japanese company Metaplanet Inc has increased its Bitcoin holdings to boost its balance sheet and stock market performance.

The company’s Bitcoin strategy, similar to MicroStrategy Inc, is in response to growing institutional demand for Bitcoin.

Metaplanet Inc, a Japanese firm that runs a hotel, has purchased additional Bitcoin units to bolster its balance sheet and stock market performance. On December 23, the firm announced the acquisition of an extra 619.7 Bitcoins, bringing its total holdings to approximately 1,761.98 BTC, valued at over ¥20 billion.

The company emphasized that its Bitcoin treasury operations have continually enhanced its stock market performance. Between July 1, 2024, and September 30, 2024, the firm’s Bitcoin yield was 41.7 percent, and from October 1, 2024, to December 23, 2024, it was 309.82 percent.

Metaplanet’s Bitcoin Strategy

As a result of this strategy, Metaplanet’s stock market has surged more than 20x year-to-date to trade at around ¥3,540. The Bitcoin-focused company’s valuation has risen to nearly ¥130 billion, despite not having a major product on the market.

Metaplanet has been leveraging the global capital market to strengthen its Bitcoin strategy, similar to MicroStrategy Inc. The OTC Markets Group Inc recently listed Metaplanet’s stock market under the ticker MTPLF, allowing the company to sell more of its shares globally to buy more Bitcoins.

Earlier this year, Metaplanet announced a 10-for-1 share consolidation to enhance its liquidity. This move is in response to the growing demand for Bitcoin, which has increased significantly since last month’s victory of Donald Trump and other pro-crypto leaders in the United States.

Institutional Demand for Bitcoin

According to Coinglass’ on-chain data analysis, the supply of Bitcoin on centralized exchanges has dropped by over 200K in the past two months, standing at about 2.24 million. Institutional investors, led by Metaplanet and MicroStrategy, have continued to buy Bitcoin, and US spot Bitcoin ETFs have also been a significant source of cash inflows.

Market data shows that US spot Bitcoin ETFs have amassed Bitcoins worth over $109 billion in less than a year, led by BlackRock’s IBIT. Meanwhile, despite a recent deal with the IMF for a $1.4 billion loan, El Salvador has stepped up its Bitcoin purchase program.

After falling below the psychological target of around $100K, the BTC price has been retesting a crucial support range between $93,806 and $97,041. From a technical analysis perspective, the flagship coin must bounce back above the support level of around $93k to avoid a potential selloff towards $70K.

Crypto analyst Ali Martinez predicts that the Bitcoin price is gearing up for a new bullish rebound beyond $168K.

[prismmediawire]

BLAQClouds Property Group_ Revolutionizing Real Estate with Blockchain

BLAQClouds Property Group Inc., a subsidiary of Blaqclouds, Inc. (OTC: BCDS), focuses on blockchain-based real estate solutions.

Blaqclouds, Inc. (OTC: BCDS) announced the launch of its subsidiary, BLAQClouds Property Group Inc., which will utilize blockchain technology to revolutionize the real estate market. Key features include property tokenization, fractional ownership, and decentralized management, all facilitated by the ZEUS Blockchain. This approach aims to increase transparency, efficiency, and accessibility in real estate transactions for investors of all sizes. The company's new website, launching December 19, 2024, will serve as a central hub for its offerings, and its first commercial acquisition is imminent.

[systemtek]

OKI Develops Printed Circuit Board Technology with Stepped Copper Coin Insertion to Achieve 55 Times Better Heat Dissipation in Outer Space. The OKI Group printed circuit board (PCB) business company OKI Circuit Technology (President: Masaya Suzuki; Headquarters: Tsuruoka City, Yamagata Prefecture; “OTC” hereinafter) has successfully developed multi-layer PCB technology with stepped copper coin insertion (“stepped copper coin” hereinafter) to achieve 55 times better heat dissipation compared to conventional PCB (*1). The stepped copper coin is offered in two types, circular and rectangular, to suit the shape of the electronic component mounted on the PCB. OTC is working to develop mass-production technologies with the aim of introducing PCBs incorporating this new technology into markets for compact devices or devices used in outer space or other environments where air cooling technology cannot be used. As semiconductors have become smaller and more sophisticated, countermeasures against the heat generated when processing large volumes of data at high speed have become an issue. In cases where device miniaturization prevents the installation of cooling fans or heat sinks or in vacuum environments such as outer space where air cooling technology cannot be used, PCBs are required to have heat dissipation structures with high heat conduction efficiency capable of transferring and dissipating the heat generated by PCB-mounted electronic components to the outside such as to a casing. In 2015, OTC developed proprietary design and mass production technologies for multi-layer PCBs based on copper coin insertion. This innovation embeds cylindrical copper coins with high thermal conductivity (*2) into PCB through-holes (*3) and bonds them to heat-generating electronic components to dissipate heat to the underside of the substrate. The use of copper coins that transfer heat to the underside of the PCB achieves high heat dissipation efficiency in cases where it is not possible to mount heat-dissipating devices directly to electronic components due to dimensional constraints of the device or where heat-dissipating devices cannot be mounted to certain functional surfaces (e.g., image sensors or light-emitting components). This time, OTC has made further progress with this technology and succeeded in developing the stepped copper coin that achieves approximately twice the heat dissipation efficiency (*4). The newly developed stepped copper coin features a larger heat-dissipating area relative to the bonding surface with the heat-generating electronic component to improve heat conduction efficiency. Additionally, aiming for an optimal heat dissipation structure to suit the shape of each electronic component, a rectangular type featuring a rectangular component installation surface and rectangular heat-dissipating surface has been developed, in addition to the conventional circular type, to increase the contact area and heat-dissipating area for rectangular electronic components to improve heat dissipation efficiency. Both types can be customized to obtain an optimal heat dissipation structure for the given shapes of the mounted component and the PCB itself and the substrate thickness. According to OTC President Masaya Suzuki, the stepped copper coin enables heat dissipation structures with high heat conduction efficiency to transfer and dissipate the heat generated by PCB-mounted electronic components to the outside such as to a casing in compact devices or in environments such as outer space where air cooling technology cannot be used. Having positioned the aerospace markets as a key focal point for its EMS business, OKI provides “space-quality” manufacturing services (EMS) ranging from the design and production of PCBs certified for all seven schedules of the JAXA (Japan Aerospace Exploration Agency) standards, cables, and other core components; simulations at the design stage; component screening and process diagnostics; to device reliability evaluations and failure analysis; PCB mounting (soldering and resin sealing); and unit assembly. OKI plans to continue advancing technology development and expanding sales for the global aerospace markets. Read the full article

[credenceresearchdotblog]

Antihistamine Drugs Market is valued at approximately USD 94,725.5 million and is projected to expand at a compound annual growth rate (CAGR) of 6.90%, reaching around USD 161,543.15 million by 2032. The global antihistamine drugs market is a vital component of the pharmaceutical industry, addressing conditions caused by allergic reactions and related disorders. Antihistamines, which block histamine receptors to mitigate allergic symptoms, are widely used for treating allergies, colds, hay fever, and even some skin conditions. 

Browse the full report https://www.credenceresearch.com/report/antihistamine-drugs-market

Market Dynamics

The antihistamine drugs market has witnessed steady growth, driven by an increasing prevalence of allergies and related conditions globally. Factors such as changing lifestyles, rising pollution levels, and heightened awareness of allergic disorders have contributed to this trend. The market is further bolstered by advancements in drug formulations, which aim to improve efficacy and reduce side effects.

Key Drivers

Rising Allergy Cases: According to the World Allergy Organization, the prevalence of allergic diseases such as asthma, rhinitis, and atopic dermatitis has increased significantly. This trend fuels the demand for effective antihistamine treatments.

Improved Diagnostic Techniques: Enhanced diagnostic tools have led to better identification of allergies, enabling timely treatment and boosting the demand for antihistamine drugs.

Expanding Geriatric Population: Older adults are more susceptible to allergic reactions and chronic conditions requiring antihistamines, contributing to market growth.

OTC Accessibility: The availability of over-the-counter (OTC) antihistamines increases their accessibility to consumers, driving sales globally.

Challenges

Despite its promising growth, the antihistamine drugs market faces several challenges:

Side Effects: First-generation antihistamines are known for causing drowsiness and impairing cognitive functions, which may deter usage.

Generic Competition: The availability of generic antihistamines leads to pricing pressures, impacting revenue margins for branded drugs.

Regulatory Hurdles: Stringent regulations and approval processes can delay the launch of new antihistamine drugs, hampering market growth.

Self-Medication Risks: While OTC availability is an advantage, improper use of antihistamines can lead to adverse effects and misuse.

Trends

Shift Toward Non-Sedating Drugs: Second-generation antihistamines that minimize sedation are gaining popularity among consumers and healthcare providers.

Growth in Online Pharmacies: The convenience of online pharmacies, especially post-pandemic, has boosted the sales of antihistamine drugs.

Combination Therapies: The development of combination drugs that address multiple allergy symptoms simultaneously is a growing trend.

Focus on Pediatric Formulations: Companies are increasingly targeting pediatric populations with specialized antihistamine formulations.

Future Outlook

The antihistamine drugs market is expected to expand steadily, fueled by continuous advancements in drug development and growing healthcare investments. The integration of technology, such as AI for drug discovery, and the focus on personalized medicine will further shape the market's trajectory.

Key Player Analysis:

Bayer AG

Almirall S.A

GlaxoSmithKline

Johnson and Johnson

Sanofi

Pfizer Inc.

Sun Pharmaceutical Industries Limited

Merck & Co. Inc.

Teva Pharmaceutical Industries Ltd.

Abbott Laboratories

Viatris Inc.

Arlak Biotech

Aden Healthcare

Sandoz Group AG

Segmentation:

Based on Product Type:

First-Generation Antihistamines

Second-Generation Antihistamines

Based on Technology:

Traditional Formulations

Advanced Delivery Systems

Based on End-User:

Hospitals

Clinics

Retail Pharmacies

Online Pharmacies

Based on Region:

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Italy, Spain)

Asia-Pacific (China, India, Japan, Australia, South Korea)

Latin America (Brazil, Argentina, Chile)

Middle East and Africa (South Africa, UAE, Saudi Arabia)

Browse the full report https://www.credenceresearch.com/report/antihistamine-drugs-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[hexcellenceconsult]

How IPO Strategy Development Can Maximize Your Company’s Market Potential

When considering an Initial Public Offering (IPO), one of the most crucial steps is developing an effective IPO strategy. A well-thought-out IPO strategy can significantly enhance your company’s market potential by positioning it for success in the public markets. With the right IPO advisory and expertise, your company can maximize investor interest and raise the capital necessary for growth. In this post, we’ll explore how strategic planning can make a significant difference in your IPO journey.

1. Defining Clear Objectives for the IPO

The first aspect of IPO strategy development is defining your company’s objectives for going public. These goals could include raising capital for expansion, paying off debt, or increasing brand visibility. By identifying clear objectives, you can tailor your IPO strategy to align with these goals. An experienced IPO consultation firm will help you prioritize these objectives and create a roadmap for achieving them, ensuring that your offering is structured to meet your company’s specific needs.

2. Structuring the IPO to Appeal to Investors

Effective IPO structuring is a key part of your strategy development. This involves deciding how many shares to offer, at what price, and what portion of the company will be made available to the public. A well-structured IPO helps create the right balance between raising enough capital for growth while keeping control of the company. Your IPO advisory team will assist in structuring the offering to make it attractive to investors while keeping your company’s long-term interests in mind.

3. Pricing Strategy to Maximize Capital Raising

Pricing is one of the most important factors in any IPO. Setting the right price ensures that the offering is attractive to investors while allowing your company to raise the required capital. The IPO pricing process takes into account market conditions, investor sentiment, and the financial health of your company. IPO pricing strategies are critical to avoid undervaluation or overpricing, both of which can affect the success of the IPO. With expert IPO guidance, you can ensure that the pricing reflects the true value of your company.

4. Investor Communication and Roadshow Preparation

Part of any IPO strategy is effectively communicating your company’s story to potential investors. This is typically done through an IPO roadshow, where you present your company’s potential, growth prospects, and market position to institutional investors. A compelling and well-executed roadshow can generate significant investor interest and set the stage for a successful IPO. With the help of IPO services, you can develop a targeted marketing and communication strategy that resonates with investors.

5. Post-IPO Market Performance and Growth

Finally, an effective IPO strategy includes a post-IPO plan that focuses on market performance and sustainable growth. By working with an IPO consulting firm, you can develop strategies to ensure your company’s success after the IPO, including investor relations and market positioning.

An expertly developed IPO strategy is essential for maximizing your company’s market potential. With the right IPO preparation, guidance, and execution, your company can successfully navigate the public offering process and unlock new opportunities for growth.

Author: Hexcellence Consultancy

Who We Are

Hexcellence Consultancy is an international advisory firm, the partner of Dude Business Group in ASEAN region. Our firm is professional and experienced corporate advisory firm that specializes in company restructuring, listing on US Capital Markets, namely Nasdaq, NYSE, and OTC Markets, as well as all aspects of going public. We work closely with clients throughout the entire listing process, communicating with third parties such as U.S. Securities and Exchange Commission, independent accountant, security attorney, and more. In addition to listing services, we offers comprehensive advisory services for general corporate operations, business transactions, and regulatory matters. We approach our work with a proactive mindset, focusing on avoiding potential problems and providing cutting-edge corporate advisory services to build long-lasting relationships with clients. The firm continuously evolves to stay current with industry trends and regulatory changes.

Contact Us

Hexcellence Consultancy

E-21-05, Menara Suezcap 2, KL Gateway, 2, Jalan Kerinchi, Wilayah Persekutuan, Kuala Lumpur, 59200, Malaysia

+60 11 5636 6286

info@hexcellence.co

https://hexcellence.co/

Find Us On Social Media

Facebook

LinkedIn

Instagram

To Know More

Brand Map

[xtruss]

FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review

— November 07, 2024 | FDA Press Release

A bottle of Vicks DayQuil cold and flu medicine containing phenylephrine is displayed for sale in a CVS Pharmacy store in Hawthorne, California, on Sept. 12, 2023. Patrick T. Fallon | AFP | Getty Images

Key Points:

The Food and Drug Administration proposed ending the use of a common ingredient in many popular over-the-counter cold and allergy medications because it doesn't actually relieve nasal congestion.

The FDA said the proposed order is not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now.

A final order will force pharmacies to clear shelves of hundreds of products containing oral forms of the ingredient, which is found in versions of drugs such as NyQuil, Benadryl, Sudafed and Mucinex.

Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the temporary relief of nasal congestion after an agency review of the available data determined that oral phenylephrine is not effective for this use. For now, companies may continue to market OTC monograph drug products containing oral phenylephrine as a nasal decongestant. This is a proposed order. Only a final order will affect what products can be marketed. The proposed order is based on effectiveness concerns, not on safety concerns.

Currently, oral phenylephrine is widely used as a nasal decongestant active ingredient in many OTC monograph drug products. It is important to note that some products only contain oral phenylephrine as a single, active ingredient. Others contain oral phenylephrine and another active ingredient (e.g., acetaminophen or dextromethorphan), and the presence of oral phenylephrine in these medicines does not affect how other active ingredients work to treat the symptoms for which they are intended.

“It is the FDA’s role to ensure that drugs are safe and effective,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER). “Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step in the process to propose removing oral phenylephrine because it is not effective as a nasal decongestant.”

The agency conducted a comprehensive review of all available data on the safety and efficacy of oral phenylephrine, including the historical data that were used to support the determination made 30 years ago that oral phenylephrine was effective as a nasal decongestant, as well as newer clinical data on oral phenylephrine that have since become available.

Last fall, the FDA also held a Nonprescription Drug Advisory Committee meeting to discuss the ‘Generally Recognized as Safe and Effective’ (GRASE) status of oral phenylephrine as a nasal decongestant. The committee discussed new data on the effectiveness of orally administered phenylephrine and unanimously concluded that the current scientific data do not support that the recommended dosage in the OTC cold, cough, allergy, bronchodilator and antiasthmatic drug products monograph for orally administered phenylephrine’s effectiveness as a nasal decongestant.

“Consumers should know that a range of safe and effective drugs and other treatments is available to temporarily relieve congestion symptoms due to allergies or a common cold,” said Theresa Michele, M.D., director of the Office of Nonprescription Drug Products in CDER. “Consumers can also talk to their doctor or pharmacist about ways to treat these symptoms.”

Over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex on the shelf. (Jeffrey Greenberg/Universal Images Group via Getty Images)

Because a variety of different drug products may be sold under the same brand name, consumers should always read the Drug Facts label to determine which ingredients are in a medication, and to be aware of important warnings and directions for use. Phenylephrine is also an ingredient in nasal sprays to treat congestion. The FDA’s action is only related to orally administered phenylephrine and not the nasal spray form.

The FDA is seeking public comments on this proposed order. Instructions on how to submit comments are found in the proposed order available on OTC Monographs@FDA. If, after considering the comments, the FDA concludes oral phenylephrine is not effective as a nasal decongestant, the FDA will issue a final order removing oral phenylephrine from the OTC monograph, and drug products thereafter could no longer contain oral phenylephrine as a nasal decongestant. The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove such drugs from the market.

Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. On Tuesday, Sept. 12, 2023 advisers to the Food and Drug Administration said that a different ingredient, phenylephrine, is ineffective at relieving nasal congestion. Drugmakers reformulated their products with phenylephrine after a 2006 law required pseudoephedrine-containing medications be sold from the behind pharmacy counter. (AP Photo, File)

— The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.

[cryptoroadmap247]

Goats Airdrop Listing & Withdraw Confirm | GOATS Pre-Market OTC Live on ...

$GOATS Pre-Market OTC Trading will be Live on #Gateio Soon! 🐐🪙 ⏰ Trading starts: 08:00 AM Nov 6th, 2024 (UTC)

⚠️ Less than 6 HOURS left till the GOATS Halloween Fes: CANDY IN - $TON OUT wraps up! ⚠️

Time’s running out to grind and spend every last bit of that Candy! 🍬💸

Remember: use it all, stack it all — over 5+ $TON rewards up for grabs! 💰

Jump in NOW or miss out big time for $TON and $GOATS!

🚀 Less than 2 days left to take advantage of the GOATS to Glory boost!

The $GOATS TGE is so close you can feel it! Time to grind hard and claim every $GOATS you can.

Every move counts – don’t miss your shot to maximize gains for

The GOATS airdrop on Telegram is a marketing campaign designed to introduce and distribute GOATS tokens to the user community. By leveraging Telegram as a platform, this airdrop aims to expand GOATS' user base, increase interaction in the community, and encourage token adoption. In this airdrop program, participants are usually asked to follow a number of steps such as:

1. Join the GOATS Official Telegram Channel or Group - Participants are required to become members of the group or channel to receive important announcements and follow the latest developments.

2. Fill out the Registration Form - This form usually includes basic information as well as related social media account details, such as a Twitter account or crypto wallet.

3. Perform Social Media Tasks - Often participants are asked to perform certain tasks such as retweeting, liking, or sharing official GOATS content on Twitter or other platforms. This helps expand the reach of GOATS promotions organically.

4. Refer a Friend - Some airdrops provide additional tokens if participants invite friends to join via a referral link, further encouraging the spread of tokens to the wider community. Tokens distributed via this airdrop are usually given after all tasks are fulfilled and verified by the GOATS team. The number of tokens received varies, depending on the distribution scheme that has been established, as well as the level of participation of each participant. These airdrops are often an opportunity for users to collect new tokens before they are officially listed on an exchange, which can provide potential profits if the value of the token increases after listing.

GOATS has quickly gained attention in the meme coin space, amassing a significant following. With its innovative Telegram mini-app and viral appeal, GOATS is preparing for a major airdrop event. If you’re looking to capitalize on this airdrop and claim your free GOATS tokens, it’s essential to understand what GOATS is, the eligibility criteria, and how to participate. $GOATS is rapidly gaining traction as a popular Telegram mini-app, attracting millions of active users, alongside the buzz and success of other Telegram-based games like Hamster Kombat, X Empire, and Blum.

Read: Top Telegram tap-to-earn games

What is GOATS Token? GOATS Token is a rising meme coin that has rapidly gained traction within the crypto community. It positions itself as more than just a meme coin by offering a unique utility within the Telegram ecosystem. Through its Telegram mini-app, GOATS allows users to interact with their tokens directly on the platform, enhancing accessibility and user engagement.

One of the most talked-about events in the GOATS ecosystem is the GOATS Airdrop—a strategic initiative aimed at expanding its user base and distributing tokens to loyal and new participants. With over 20 million users already engaged, the airdrop is anticipated to be one of the largest in the meme coin market amid the ongoing memecoin supercycle. The GOATS airdrop listing date is eagerly awaited by users keen to capitalize on this opportunity.

Read: Top memecoins 2024

GOATS Airdrop Eligibility Criteria The GOATS team has set specific eligibility criteria for participants to ensure a fair and balanced distribution of tokens. Here are the key factors that determine who is eligible for the airdrop:

Telegram Mini-App Engagement: GOATS’ airdrop is primarily based around its Telegram mini-app. To qualify for the airdrop, users must be actively engaged with the GOATS Telegram app. This includes creating an account within the app and completing tasks such as joining groups, participating in community activities, and referring friends to the app. Holding a Minimum Number of GOATS Tokens: Some eligibility criteria revolve around holding a minimum number of GOATS tokens in your wallet. This requirement ensures that early supporters and holders of GOATS tokens are rewarded for their loyalty to the project. Make sure to check the Telegram GOATS listing date for the official token requirements before participating. Referral Programs: GOATS emphasizes community participation, and one way to increase your airdrop allocation is through referrals. By inviting friends to join the Telegram GOATS mini-app, users can boost their eligibility and potentially claim more tokens. Keep an eye on GOATS airdrop new date announcements for additional referral opportunities. Active Social Media Participation: GOATS often hosts social media campaigns where users can gain extra tokens by sharing content, using specific hashtags, or creating memes about the GOATS ecosystem. Being active on platforms like Twitter and participating in official campaigns can increase your airdrop rewards. How to Claim GOATS Airdrop Once you have confirmed your eligibility, the next step is to claim your tokens. Follow these steps to ensure you can successfully claim the GOATS airdrop:

Sign Up for the GOATS Telegram Mini-App: Start by signing up for the GOATS mini-app within Telegram. This will be your central hub for interacting with the GOATS ecosystem, checking your token balance, and receiving airdrop notifications. Complete the Necessary Tasks: Make sure you fulfill all the eligibility criteria, including holding the minimum number of tokens, completing KYC, and participating in community activities. Check for official updates on the GOATS airdrop new date to ensure you don’t miss any deadlines. Monitor the Airdrop Listing Date: The official GOATS airdrop listing date will be announced via the Telegram mini-app and other official channels. Once the airdrop is live, eligible users will receive their tokens automatically in their wallets. Keep track of updates, especially on Twitter and other GOATS community channels, for real-time information. We will be updating this article as well, so keep an eye out on this space as well! Claim Your Tokens: When the airdrop begins, eligible users will receive a notification within the Telegram app to claim their GOATS tokens. Simply follow the on-screen instructions to transfer the airdropped tokens into your wallet. Stay Updated for Future Airdrops: GOATS is expected to roll out more airdrop campaigns as it progresses toward its listing date. Following their social channels will ensure you’re always in the loop for upcoming events and potential bonus tokens. Conclusion The GOATS airdrop represents a major opportunity for early adopters and active community members to earn free tokens and get involved in the future of this rapidly growing meme coin. By meeting the eligibility criteria and staying engaged with the Telegram app, you can easily claim your share of the GOATS airdrop. With the official GOATS airdrop listing date approaching, now is the perfect time to prepare and maximize your potential earnings. Stay tuned for the latest updates on the GOATS project and its progress toward becoming a major player in the crypto market.

This detailed guide ensures that you don’t miss out on claiming your free GOATS tokens and participating in the next phase of its exciting journey.

[chemistwarehouse2]

Chemist Warehouse: A Leader in Australian Retail Pharmacy

Chemist Warehouse is one of Australia's most recognizable names in retail pharmacy, often referred to as "Australia’s Cheapest Chemist." With over 500 stores across Australia, New Zealand, and even some expansion into China, Chemist Warehouse has become a household name synonymous with affordable healthcare, prescription medications, and a wide variety of consumer goods.

Origins and Growth Chemist Warehouse was founded in 2000 by Mario Verrocchi and Jack Gance, building on their vision of offering customers competitive prices on pharmaceutical products. Unlike traditional pharmacies that focus more on providing personal service, Chemist Warehouse adopted a high-volume, low-cost model that allowed them to offer substantial discounts on products ranging from prescription medications to everyday essentials like skincare, supplements, and baby care items.

This business model has proven incredibly successful. The company's rapid expansion was driven by their ability to offer prices lower than traditional pharmacies, often by as much as 50%. Chemist Warehouse has capitalized on bulk purchasing and streamlined operations, passing on these savings to consumers.

Pricing and Accessibility The affordability of Chemist Warehouse products has been a key driver of its success. Consumers looking for over-the-counter medications, beauty products, vitamins, and even fragrances often find Chemist Warehouse as the go-to destination. Their slogan, "Why Pay More?", resonates strongly in an environment where healthcare costs can be significant.

Chemist Warehouse is also known for running regular sales and promotions, further driving customer loyalty. The company’s online store has expanded its reach beyond the physical outlets, offering customers the convenience of shopping from home and receiving their orders delivered.

Product Range and Services In addition to pharmaceuticals, Chemist Warehouse stocks an extensive range of health and wellness products, making it a one-stop shop for many consumers. Some key product categories include:

Prescription Medications: As a licensed pharmacy, Chemist Warehouse offers all major prescription drugs at highly competitive prices. Over-the-Counter Medications: The company sells a variety of OTC medications, including pain relief, cold and flu treatments, and allergy medications. Health Supplements: Customers can find a broad range of vitamins, minerals, and herbal supplements. Beauty and Skincare: Chemist Warehouse carries a vast selection of beauty products, including popular skincare brands, cosmetics, and personal care items. Fragrances: One of the unexpected areas of growth for Chemist Warehouse has been its range of discount fragrances, appealing to consumers looking for affordable luxury. Apart from product variety, the stores also provide pharmaceutical services like prescription refills, health checks, and consultations, ensuring that customers receive professional healthcare advice alongside their purchases.

Online Presence and International Expansion Chemist Warehouse’s e-commerce platform has played a critical role in its business strategy, offering customers nationwide access to its wide product range. The brand’s click-and-collect service allows customers to order online and pick up in-store, adding to its convenience.

In addition to its dominance in Australia, Chemist Warehouse has expanded internationally, with stores in New Zealand and early ventures into China through partnerships and online marketplaces like Alibaba’s Tmall Global. This international expansion has allowed Chemist Warehouse to tap into the growing demand for trusted Australian health products in overseas markets, especially in Asia, where Australian-made goods are highly regarded for their quality.

Challenges and Criticism Despite its success, Chemist Warehouse has faced its share of challenges. The company has been criticized by smaller pharmacies and industry groups for undercutting prices and monopolizing the market. Some argue that its aggressive pricing strategy has put immense pressure on independent pharmacies, making it difficult for them to compete.

There have also been labor-related disputes, with some employees raising concerns about working conditions and wages. However, Chemist Warehouse has made efforts to address these issues over time.

The Future of Chemist Warehouse Chemist Warehouse continues to evolve, with plans for further growth both domestically and internationally. The company has adapted to changing consumer behaviors, particularly with the rise of online shopping, and remains at the forefront of retail pharmacy innovation.

With a focus on affordable healthcare, a broad product offering, and the ability to adapt to market demands, Chemist Warehouse is likely to remain a dominant force in the retail pharmacy industry for years to come.

Conclusion Chemist Warehouse has revolutionized the pharmacy industry in Australia by combining affordability, accessibility, and convenience. Its aggressive pricing model has not only disrupted the market but also provided significant benefits to consumers, making healthcare and everyday essentials more affordable for millions of people.

While it faces competition and criticism, Chemist Warehouse continues to thrive, expanding its influence in both physical and digital retail spaces. The company’s commitment to providing value for money ensures that it will remain a trusted name in Australian homes and beyond.

[industryforecastnews]

Rheumatoid Arthritis Therapeutics Market To Reach USD 36.39 Billion By 2030

Rheumatoid Arthritis Therapeutics Market Growth & Trends

The global rheumatoid arthritis therapeutics market size is expected to reach USD 36.39 billion by 2030, expanding at a CAGR of 5.93% from 2024 to 2030, according to a new study by Grand View Research, Inc. Some of the key trends driving the market are availability of novel biologics, increase in potential clinical pipeline candidates, and rise in aging population. Thus, growing availability and awareness of safer drugs are projected to escalate rheumatoid arthritis drugs market growth. 

Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities. Over a prolonged period, this disorder can hamper a patient’s mobility and can lead to permanent joint damage. If left untreated, this disorder can lead to mobility impairment and risk of joint replacement.

Growing prevalence of the disease, presence of biologics & biosimilars, and well-defined regulatory guidelines are poised to provide a fillip to the market. According to the Arthritis Foundation, 64% of the population within the age group of 65 is likely to suffer from arthritis in U.S. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth.

Current treatment for rheumatoid arthritis includes generic pharmaceuticals such as NSAIDs and corticosteroids along with novel biologics such as JAK inhibitors and IL-6 antagonists, which are widely used in developed countries due to their high effectiveness. New product launches such as Infliximab and Adalimumab biosimilars are anticipated to work in favor of the market. Moreover, Eli Lilly’s Olumiant and AbbVie’s Upadacitinib are expected to cut down chances of disease remittance.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market

Rheumatoid Arthritis Therapeutics Market Report Highlights

Biopharmaceuticals segment led the market and accounted for 88.73% of the global revenue in 2023. Biopharmaceuticals are large-molecule drugs that are manufactured, extracted, and synthesized from biological sources.

Prescription led the market with a market share of 89.64% in 2023. As rheumatologist consultations rise, the prescription segment is expected to remain dominant in the market for rheumatoid arthritis medications over the forecast period.

North America rheumatoid arthritis therapeutics market accounted for 52.31% share in 2023. The regional market continues to grow and evolve, driven by demographic shifts, advancements in medical research, regulatory changes, and an increasing emphasis on personalized healthcare.

The Asia Pacific rheumatoid arthritis therapeutics market is experiencing significant growth, driven by the increasing prevalence of rheumatoid arthritis, improving healthcare infrastructure, and advancements in treatment options.

Rheumatoid Arthritis Therapeutics Market Segmentation

Grand View Research has segmented global rheumatoid arthritis therapeutics market report based on molecule, sales channel, and region:

Rheumatoid Arthritis Therapeutics Molecule Outlook (Revenue, USD Million, 2018 - 2030)

Pharmaceuticals

NSAIDs

Analgesics

DMARDs

Glucocorticoids

Biopharmaceuticals

Biologics

TNF-α antagonists

T-cell inhibitors

CD20 antigen

JAK inhibitors

anti-IL6 biologics

Biosimilars

CD20 antigen

TNF-α antagonists

Rheumatoid Arthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

Prescription

Over-the-Counter (OTC)

Regional Insights

North America rheumatoid arthritis therapeutics market accounted for 52.31% share in 2023.The regional market continues to grow and evolve, driven by demographic shifts, advancements in medical research, regulatory changes, and an increasing emphasis on personalized healthcare. The aging population across the region significantly impacts the demand for rheumatoid arthritis therapeutics. As people live longer, the prevalence of chronic conditions such as RA increases, boosting the need for effective treatment options. This demographic trend is a primary driver of sustained market growth.

Europe Rheumatoid Arthritis Therapeutics Market Trends

The Europe rheumatoid arthritis therapeutics market is substantially changing, influenced by healthcare reforms, research advancements, and patient-focused initiatives across different countries. The prevalence of rheumatoid arthritis is increasing due to an aging population and changing lifestyles, leading to a growing demand for effective & innovative treatment options across the continent.

Asia Pacific Rheumatoid Arthritis Therapeutics Market Trends

The Asia Pacific rheumatoid arthritis therapeutics market is experiencing significant growth, driven by the increasing prevalence of rheumatoid arthritis, improving healthcare infrastructure, and advancements in treatment options. The prevalence of rheumatoid arthritis is on the rise across Asia Pacific due to factors such as the aging population, changing lifestyles, and increasing awareness leading to early diagnosis. This rising prevalence has led to a growing demand for effective and affordable RA treatments, prompting healthcare providers & policymakers to focus on improving RA care & management.

List of Key Players of Rheumatoid Arthritis Therapeutics Market

AbbVie, Inc.

Boehringer Ingelheim International GmbH

Novartis AG

Regeneron Pharmaceuticals Inc.

Pfizer, Inc.

Bristol-Myers Squibb Company

F. Hoffmann-La Roche Ltd.

UCB S.A.

Johnson & Johnson Services, Inc.

Amgen, Inc.

Lilly (Eli Lilly and Company)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/rheumatoid-arthritis-therapeutics-market

[prismmediawire]

AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business

NEW YORK, Dec. 03, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company entered into Repurchase Agreements with four shareholders, all non-affiliates of the Company, pursuant to which the Company agreed to repurchase shares of their Common Stock, $0.001 par value, amounting to 300,000,000 shares for cancellation. The price to be paid by the Company under the Repurchase Agreements is $390,000, which will be funded with cash on hand.

ABQQ today announced its intention to spin off its Non-Fungible Token (NFT) MMM IP and Artificial Intelligence (AI) Consulting division into a separate entity, with plans for this new company to go public. This strategic move aims to unlock shareholder value by allowing each business unit to pursue its own growth strategies independently while capitalizing on the burgeoning markets for NFTs and AI technologies.

Details of the Spin-off:

- Entity Name: The new entity, tentatively named AB Digital Innovations, will focus exclusively on the development and commercialization of NFT marketplaces, AI consulting services, and related intellectual properties.

- Business Model: AB Digital Innovations will leverage ABQQ's existing infrastructure in the NFT IP space, including the NFT Movie and Music Marketplace (NFT MMM), and expand into broader AI consulting services aimed at enhancing film production, distribution, and consumer engagement through AI technologies.

- Strategic Rationale: The spin-off is designed to provide clearer market focus, potentially attract specialized investment, and offer investors a pure-play opportunity in the rapidly evolving sectors of digital assets and AI.

- Public Offering: Details regarding the timing and terms of the initial public offering (IPO) for AB Digital Innovations will be communicated in due course. The company is currently preparing the necessary documentation and regulatory compliance activities for listing.

Benefits for Existing ABQQ Shareholders:

1. Value Unlocking:

- The spin-off, bolstered by significant external investment, is expected to more clearly delineate the value of each business segment, potentially leading to increased market valuation for shareholders.

2. Investment Opportunity:

- Shareholders will receive shares in AB Digital Innovations, providing them not only with a stake in a new high-growth area but also the benefits from a substantial investment in the company.

3. Higher Potential Returns:

- The investment and spin-off could lead to higher returns for shareholders as both entities can now pursue more aggressive growth strategies tailored to their niche markets.

4. Increased Market Attention:

- The significant investment underscores the market's confidence in the potential of AB Digital Innovations, likely drawing additional interest from investors, which could enhance stock liquidity and market visibility.

"This spin-off is a testament to our commitment to innovation and growth. By separating our NFT and AI initiatives, we believe we can better tailor our strategies to meet the unique demands of these markets, thereby enhancing value for our stakeholders." - Chiyuan Deng, CEO of AB International Group Corp.

"We are excited about the potential this separation offers. It allows us to directly tap into the investor interest in NFTs and AI, sectors that are seeing unprecedented growth and investor enthusiasm." - Charles Tang, Investor Relations.

About AB International Group Corp.

AB International Group Corp. is an intellectual property (IP) and movie investment and licensing firm, focused on acquisitions and development of various intellectual property. We are engaged in acquisition and distribution of movies. The company owns the IP of the NFT movie and music marketplace (NFT MMM) as the unique entertainment industry Non-Fungible Token. The Company operates AB Cinemas, physical movie theaters currently in NY with plans to expand nationwide (www.abcinemasny.com). The company also owns ABQQ.TV which is a movie and TV show online streaming platform. ABQQ TV generates revenue through a hybrid subscription model and advertising model like other online streaming platforms.

For additional information, visit www.abqqs.com, www.abcinemasny.com, www.stareast.io, and www.ABQQ.tv.

Forward-Looking Statements

This press release contains “forward-looking statements” that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to changes to the Company’s management team and statements relating to the Company’s transformation, financial and operational performance including the acceleration of revenue and margins, and the Company’s overall strategy. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the possibility of business disruption, competitive uncertainties, and general economic and business conditions in AB International Group markets as well as the other risks detailed in company filings with the Securities and Exchange Commission. AB International Group undertakes no obligation to update any statements in this press release for changes that happen after the date of this release.

Investor Relations Contact:

Charles Tang (852) 2622 2891 corp@abqqs.com  

Source: AB International Group Corp.

[nphealthcare24]

Empowering Your Healthcare Vision: Partner with NP Healthcare for a Lucrative PCD Pharma Franchise in India

NP Healthcare stands apart as a main PCD (Propaganda cum Distribution) Pharma Franchise company in India.We offer an extraordinary chance for business visionaries and laid out organizations to flourish in the unique Indian drug market. Here's the reason NP Medical care ought to be your accomplice of decision:

Unmatched Quality and Product Portfolio:

Unflinching Obligation to Greatness: We focus on the prosperity of patients by assembling and dispersing first class drug items across different remedial portions. Our severe adherence to WHO and GMP rules guarantees the greatest norms.

Various Item Reach: We take care of an extensive variety of medical services needs with a broad portfolio incorporating:

Professionally prescribed drugs

Over-the-counter (OTC) drugs

Nutraceuticals

Topical formulations

Building Your Success: A Supportive Ecosystem

Exclusive Monopoly Rights: NP Healthcare empowers its franchise partners with exclusive monopoly rights in designated territories. This kills contest from other NP Medical care establishments, permitting you to construct areas of strength for a presence and boost benefit.

Worthwhile Overall revenues: We offer serious net revenues on our items, guaranteeing a solid profit from your venture. Our evaluating procedure offsets moderateness for customers with your procuring potential.

Comprehensive Marketing & Promotional Support: We understand the importance of effective marketing. We provide extensive support with:

Free physician samples to encourage product adoption

A range of marketing materials like MR bags, visual aids, and promotional tools

Regular training programs to enhance your sales and marketing skills

A Tradition of Trust and Organization

Moral Strategic policies: Respectability shapes the foundation of our business reasoning. We put stock in straightforward dealings and fair associations.

Devoted Client assistance: Our group is focused on offering remarkable help to our establishment accomplices. We offer brief help with inquiries, request handling, and coordinated factors.

Cooperative Development: We view our establishment accomplices as an augmentation of the NP Medical services family. We cooperate to accomplish shared objectives and guarantee the progress of your business.

Putting resources into Your Future with NP Healthcare

By partnering with NP Healthcare, you gain access to:

A Renowned Brand: We have established a strong reputation for quality and reliability in the Indian pharmaceutical sector. This memorability means an upper hand for your business.

Experienced Initiative: Our group involves industry veterans with a demonstrated history of progress. We influence their skill to guide and support your development process.

Continuous Innovation: NP Healthcare is committed to ongoing research and development. We strive to introduce new and effective products to cater to evolving healthcare needs.

Taking the Next Step

NP Healthcare offers a compelling opportunity to build a rewarding career in the Indian pharmaceutical landscape. If you're a passionate entrepreneur or a business seeking expansion, we invite you to explore our Best PCD Pharma Franchise Company in India.

Contact us today to schedule a consultation and learn more about how NP Healthcare can empower your vision for a successful and impactful healthcare business.